BIB.US ProShares Ultra Nasdaq Biotechnology

- USD
No recent price
Total assets
107M
Expense ratio
0.95%
Dividend yield
0.19%
1-year return
+65.81%
Holdings
245
Since
2010

Fund data as reported by the issuer, updated Nov 14, 2026. Total assets are in the fund's base currency.

What does BIB.US invest in?

  • Mostly US stocks (63.4%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (99.1%)
  • Top 3 holdings: 25.5% of the fund

Asset allocation

  • US stocks 63.4%
  • Cash 24.1%
  • Other 10.7%
  • Non-US stocks 3.4%

Top holdings

All holdings, sectors and regions

ProShares Ultra Nasdaq Biotechnology performance

Sharpe ratio 1.06
This year
+53.08%
1 year
+65.81%
3 years
+42.95%
5 years
+8.00%

Volatility 31.6% over 1 year and 33.4% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

BIB.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About ProShares Ultra Nasdaq Biotechnology

The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

Full fund profile